Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.370 | 9.710 | 8.340 |
Stocks | 98.630 | 98.630 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 33.235 | 35.618 |
Price to Book | 4.698 | 6.291 |
Price to Sales | 3.019 | 3.595 |
Price to Cash Flow | 25.992 | 28.729 |
Dividend Yield | 1.151 | 0.932 |
5 Years Earnings Growth | 10.858 | 14.684 |
Name | Net % | Category Average |
---|---|---|
Consumer Defensive | 48.730 | 30.786 |
Consumer Cyclical | 32.680 | 40.601 |
Energy | 10.170 | 10.170 |
Healthcare | 5.830 | 4.222 |
Financial Services | 2.580 | 8.665 |
Number of long holdings: 21
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ITC | INE154A01025 | 9.43 | 455.15 | +0.18% | |
Reliance Industries | INE002A01018 | 9.16 | 1,285.20 | +3.15% | |
Aditya Birla Fashion | INE647O01011 | 8.07 | 285.65 | -0.12% | |
Nestle India | INE239A01024 | 7.81 | 2,299.45 | -0.76% | |
Zydus Wellness | INE768C01010 | 7.31 | 1,782.60 | -4.12% | |
Marico | INE196A01026 | 7.20 | 677.05 | +0.55% | |
M.R.F. | INE883A01011 | 6.05 | 114,934.70 | +1.00% | |
Bata India | INE176A01028 | 5.68 | 1,368.35 | -3.32% | |
Suraksha Diagnostic | INE877V01027 | 5.26 | 317.50 | +1.89% | |
Titan Company | INE280A01028 | 5.07 | 3,597.70 | +0.49% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
INF966L01689 | 266.7B | 23.50 | 26.68 | 21.17 | ||
INF966L01051 | 266.7B | 22.35 | 25.17 | 20.33 | ||
Quant Mid Cap Fund Growth | 88.91B | 18.94 | 23.32 | 18.11 | ||
INF966L01887 | 88.91B | 20.27 | 25.31 | 19.28 | ||
Quant Consumption Fund Growth | 71.85B | 15.28 | 18.45 | 18.33 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review